Welcome to LookChem.com Sign In|Join Free
  • or
2,4-diamino-5-[[(2',5'-diethoxyphenyl)imino]methyl]-pyrrolo[2,3-d]pyrimidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

166047-46-7

Post Buying Request

166047-46-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

166047-46-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 166047-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,0,4 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 166047-46:
(8*1)+(7*6)+(6*6)+(5*0)+(4*4)+(3*7)+(2*4)+(1*6)=137
137 % 10 = 7
So 166047-46-7 is a valid CAS Registry Number.

166047-46-7Upstream product

166047-46-7Downstream Products

166047-46-7Relevant academic research and scientific papers

Pyrrolo?2,3d!derivatives

-

, (2008/06/13)

Pyrrolo?2,3-d!pyrimidine derivatives, and pharmaceutical acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness are disclosed.

Pyrimidine derivatives and methods of making and using these derivatives

-

, (2008/06/13)

This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. The compounds themselves, methods of making these compounds, and methods of using these compounds are all disclosed.

Pyrrolo pyrimidine and furo pyrimidine derivatives

-

, (2008/06/13)

This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. The compounds themselves, methods of making these compounds, and methods of using these compounds are all disclosed. More specifically, the compounds include pyrrolo?2,3-d!pyrimidines and furo?2,3-d!pyrimides and derivatives thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 166047-46-7